The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.
“Time is quickly running ...
A guide to contemporary doomsday scenarios — from the threats you know about to the ones you never think of.
And here we are at the crux of our existential ...
From the philosophers whose moral imagination pushes the boundaries of what is possible to the activists making the world a better and healthier place on the ground, from the ...
Sanofi has teamed up with Scribe Therapeutics to write the next chapter in its natural killer (NK) cell therapy story, paying $25 million upfront and committing to $1 billion ...
Scribe Therapeutics Inc., a molecular engineering company pioneering a CRISPR by Design™ platform for genetic medicine, today announced a strategic collaboration with Sanofi for the use of Scribe’s CRISPR ...
The following is an excerpt of The Atlantic opinion editorial by CRISPR co-inventor and Nobel Prize-winner Dr. Jennifer Doudna.
CRISPR is changing the world - but it can do more.
Two ...
CRISPR is a family of DNA sequences found in the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments of viruses called ...
Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with ...
It’s entirely possible, maybe even likely, that during some slow day at the lab early in her career, Jennifer Doudna, in a moment of private ambition, daydreamed about making ...
“CRISPR-by-design” is the idea behind Scribe Therapeutics, a company spun out from Jennifer Doudna’s Nobel-winning lab that’s competing in a closely-tracked field of genome editor companies just starting to ...
Jennifer Doudna was staring at a computer screen filled with a string of As, Cs, Ts, and Gs—the letters that make up human DNA—and witnessing a debilitating genetic disease ...
On June 28, 2012, a joint press release went out from the U.S. Department of Energy and the Lawrence Berkeley National Laboratory announcing a new paper in Science from an ...
The gene-editing tool has transformed the study of human disease, but before it can revolutionize treatments, researchers will need to solve three basic problems.
Ten years ago this week, a report of ...
The gene-editing technology has led to innovations in medicine, evolution and agriculture — and raised profound ethical questions about altering human DNA.
Ten years ago this week, Jennifer Doudna and ...
New funding from the Chan Zuckerberg Initiative kickstarts CRISPR-enabled carbon removal research at the Innovative Genomics Institute
A new research program at the Innovative Genomics Institute (IGI), supported by a ...
Ever since the draft of the human genome became available in 2001, there has been a nagging question about the genome’s “dark matter”—the parts of the map that were ...
Innovative Genomics Institute Founder, Nobel Laureate, and CRISPR co-discoverer Jennifer Doudna joins Emily Chang to discuss the future of the CRISPR technology and its commercialization, as well as the ...
Sixth Street Chief Science Adviser and Nobel laureate Jennifer Doudna, co-founder of the CRISPR genome editing technology, and Sixth Street Vice Chairman and Partner R. Martin Chavez join Emily ...
New innovations in gene and stem cell technology have the power to shape ecosystems and even change humanity. In this episode of NPR's TED Radio Hour hour, Jennifer Doudna ...
According to most accounts, Doudna’s history-altering discovery started over coffee with Jillian Banfield, a University of California microbiologist who spends her field seasons knee-deep in caves and abandoned mines ...
A cup of tea in 2006 changed genetic engineering forever. Jill Banfield, a University of California at Berkeley ecosystem scientist and 1999 MacArthur Foundation fellow had become curious in ...
For more than a year, Victoria Gray's life had been transformed. Gone were the sudden attacks of horrible pain that had tortured her all her life. Gone was the ...
A new crop of biotechs is looking to either improve CRISPR or develop new gene-editing techniques — and 2022 may be a crucial year in proving their value.
For all ...
2022 will be a critical year of execution for the gene-editing technology known as CRISPR. Several biotechs are advancing into human clinical trials, and the results could show the ...
Scientists are a cautious bunch, fond of a caveat even when describing their own research. “Our favourite expressions are ‘Yes, but…’ and ‘On the other hand…’ and ‘It remains ...
Benjamin Oakes is carving out a space in the gene-editing field by developing what he calls a "genetic scalpel."
After researching gene editing in the labs of CRISPR pioneer Jennifer ...
CRISPR is the latest and most powerful technique for changing the genetic code of living things. This method of gene editing is already showing great promise in treating people ...
Gene editing has become one of biotech's hottest areas as the first-in-human results have suggested the technology holds the potential to cure certain diseases with a single treatment.
In 2021, ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
Patrick Doherty had always been very active. He trekked the Himalayas and hiked trails in Spain.
But about a year and a half ago, he noticed pins and needles in ...
The gene editor CRISPR excels at fixing disease mutations in lab-grown cells. But using CRISPR to treat most people with genetic disorders requires clearing an enormous hurdle: getting the ...
Digital data related to Nobel Prize-winning inventions for gene editing and cancer immunotherapy will be sold connected to non-fungible tokens next week, a novel way for the University of ...
How much will someone be willing to pay for a few pages of quarter-century-old bureaucratic university paperwork that have been turned into a blockchain-encoded piece of digital art?
Berkeley announced ...
Tory Burch has helped thousands of women entrepreneurs through her eponymous foundation and its education programs, but very few recipients of her coveted one-year business fellowship have founded biotech ...
Fireside chats have become a staple of pandemic-era virtual events. The reasons are clear: they offer a glimpse into an otherwise private conversation and it’s entertaining to listen to ...
Last year, Jennifer Doudna and Emmanuelle Charpentier became the first all-woman team to win the Nobel Prize in Chemistry for their work developing CRISPR-Cas9, the gene-editing technology. The technology ...
In this latest "Bloomberg Studio 1.0," host Emily Chang sits down with CRISPR co-inventor and 2020 Nobel Prize winner, Dr. Jennifer Doudna. They discuss her groundbreaking work on DNA, ...
Ben Oakes’ dive inside the human mind colors his leadership role at gene editing startup Scribe Therapeutics.
As an undergrad, Ben Oakes wanted to learn how the mind worked — ...
Scribe Therapeutics is adding another $100 million to its coffers six months after unveiling a $20 million series A and a partnership with Biogen to work on gene editing ...
Scribe Therapeutics has completed an oversubscribed $100-million Series B financing, with aims to further develop its suite of custom gene-editing and delivery technologies based on molecular engineering, as well ...
